PharmaBioSource provided exclusive marketing and consulting services to sell AMRI’s small molecule API manufacturing operation located in Lodi, Italy. The Lodi operation known as Prime European Therapeutics S.p.A. (Euticals) was acquired by LIVIA Corporate Development, which specializes in acquiring European Corporate spin-offs/carve-outs. The Lodi site is specialized for the custom synthesis and manufacture of active pharmaceutical ingredients (APIs).
Whether you’re looking to streamline your business processes, buy or sell a manufacturing facility, or expedite a merger, our expert advisors are here to make it a smooth and favorable experience for you.